FDA Approves Biohaven’s Nurtec ODT (rimegepant) for Preventative Treatment of Migraine
Nurtec ODT 75 mg is the first oral CGRP antagonist approved to prevent migraine Nurtec ODT 75 mg is now […]
Biohaven’s
Nurtec ODT 75 mg is the first oral CGRP antagonist approved to prevent migraine Nurtec ODT 75 mg is now […]Biohaven’s
FDA Approves Biohaven’s Nurtec ODT (rimegepant) for Preventative Treatment of Migraine
Copyright © 2024